Rocket Lab USA Inc. (RKLB) Stock Price, News, Analysis

Technical Score (1D)

SELL

News Sentiment

BULLISH

Iridium Communications announced that its Q2 2026 earnings will be posted on July 22, with no conference call because of the pending acquisition by Rocket Lab, meaning analysts will need to sift through the press release for guidance on the combined entity’s future cash flows. The timing of the release dovetails with Rocket Lab’s recent $8 billion Iridium satellite‑connectivity deal, which is expected to add a recurring revenue stream that could lift the combined company’s earnings per share over the next few weeks. Rocket Lab’s Q1 2026 performance, highlighted by 31 launch contracts that exceed its entire 2025 volume, underscores the company’s expanding launch capacity and positions it as a stronger competitor to SpaceX, potentially boosting its valuation in the near term. The acquisition also brings an integrated satellite platform into Rocket Lab’s launch offerings, which could accelerate revenue growth from satellite services and broaden the firm’s market share in the satellite launch sector. Meanwhile, insider activity has been mixed, with a $286 million sale by CEO Peter Beck’s trust executed under a Rule 10b5‑1 plan, which may signal a liquidity need or a pre‑arranged exit strategy but does not necessarily reflect a change in confidence. The same volume of shares sold by other insiders in a separate filing adds to short‑term sentiment pressure, suggesting that traders should be cautious of volatility in the next trading days. The absence of a conference call for Iridium’s earnings means that analysts will rely heavily on the textual guidance, so any surprises in revenue or margin will be more pronounced and could trigger rapid market adjustments. In addition, the bridge loan of $3.6 billion that accompanies the Iridium deal provides liquidity, which could cushion the combined entity against short‑term cash flow pressures and support ongoing operations. Traders should therefore monitor the Q2 2026 earnings release for any updates on the integration progress, recurring revenue projections, and the impact of the bridge loan, while also keeping an eye on launch execution and any further insider activity that could influence short‑term sentiment.

RKLB|Company Info

Sector

Industrials

Industry

Aerospace & Defense

Exchange

NCM

Country

United States

Website

rocketlabcorp.com

Symbol

RKLB

Description

Rocket Lab Corporation is a space technology company specializing in end-to-end solutions for small satellite missions. The company's core business centers around providing launch services via its Electron rocket, designed to efficiently deploy small spacecraft into orbit. Beyond launch, Rocket Lab offers comprehensive space systems solutions, including spacecraft design, manufacturing, and on-orbit management capabilities. Serving commercial, government, and prime contractor clients across the United States, Canada, Japan, and internationally, the company also develops the Neutron launch vehicle to address larger-scale missions and potentially human spaceflight. Rocket Lab's integrated approach, from launch vehicles to spacecraft components, positions it to capture a significant share of the growing small satellite market.

RKLB|Earnings Snapshot

Earnings Summary

Rocket Lab Corporation (RKLB) is a space technology company that delivers end‑to‑end launch services for small satellites through its Electron rocket, while also offering spacecraft design, manufacturing, and on‑orbit management. Operating in the aerospace and defense sector, the firm is positioned to capture growth in the expanding small‑satellite market. In the most recent quarters, revenue rose from $132.4 million in Q4 2024 to $155.1 million in Q3 2025, and then to $179.7 million in Q4 2025, before climbing to $200.4 million in Q1 2026, reflecting a 35 % year‑over‑year increase in Q4 2025 and a 63 % jump in Q1 2026. Earnings per share, while still negative, improved from –$0.10 in Q4 2024 to –$0.02 in Q1 2026, and the company beat analyst expectations in the last three of its four most recent quarters, with EPS surpassing estimates in Q3 2025, Q4 2025, and Q1 2026. Historically, RKLB has shown a consistent acceleration in revenue growth and a trend toward narrowing losses, with EPS moving from –$0.13 in Q2 2025 to –$0.03 in Q3 2025 and further to –$0.07 in Q4 2025, indicating a positive trajectory even when earnings remain negative. Recent news highlights Morgan Stanley’s $293 target and the company’s successful VICTUS HAZE mission, alongside the announced $8 billion acquisition of Iridium Communications, which could broaden revenue streams but also introduces integration risks that may affect margins. Investors should watch for confirmation of the Iridium deal, any new Space Force or commercial launch contracts, and guidance on launch cadence, as these factors will be key to understanding how the pipeline and integration progress influence future earnings and revenue growth.

Read full report

EPS

EstBeatMiss

Qtr	Est	Actual	+/−
Q2'26	$-0.05	-	-
Q1'26	$-0.08	$-0.02	+75.5%
Q4'25	$-0.09	$-0.07	+25.7%
Q3'25	$-0.10	$-0.03	+71.3%
Q2'25	$-0.11	$-0.13	-17.9%
Q1'25	$-0.12	$-0.12	+0.5%

Revenue

EstBeatMiss

Qtr	Est	Actual	+/−
Q2'26	$236M	-	-
Q1'26	$193M	$200M	+3.6%
Q4'25	$182M	$180M	-1.3%
Q3'25	-	$155M	-
Q2'25	-	$144M	-
Q1'25	-	$123M	-

Full Earnings BreakdownEstimates, actuals, guidance, and historical context

→

Market Data

RKLB Stock Snapshot

RKLB is currently trading at $83.34, giving Rocket Lab USA Inc. a market cap of 49.86B. Today's range spans $82.41–$88.33, with shares opening at $86.23 and moving up $0.79 (1.0%) from the prior close. DailyIQ's technical score sits at 23/100 (SELL) with a news sentiment reading of 69/100.

Over the past year RKLB has traded between $37.57 and $151.00 - the current price is +121.8% off the 52-week low and -44.8% from the high. 28 analysts cover the stock with a Buy consensus and a mean 12-month target of $116.50 (range $76.00–$150.00), implying upside of +39.8%.

Earnings estimate risk is at the forefront for Rocket Lab USA Inc. (RKLB) - a large-cap Industrials name (49.86B market cap) showing a SELL (23/100) alongside bullish sentiment (69/100) often flags a period where consensus estimates are still catching down to what the market is already pricing in. Price: $83.34 (in the lower half of its 52-week range in $37.57–$151.00). Active managers who track the technical-fundamental gap tend to position ahead of the revision, not after it.

Analyst coverage for RKLB becomes a double-edged factor in a SELL phase: at 49.86B in Industrials market cap, active coverage is high enough that downgrade risk is real and impactful. The 23/100 technical reading and bullish sentiment (69/100) at $83.34 (in the lower half of its 52-week range) place the stock in the zone where one or two high-profile estimate cuts can convert a grinding decline into a sharper re-rating — the $37.57–$151.00 range establishes where that repricing lands.

News Sentiment Analysis

Sentiment gathered from recent headlines

69/100

Strong NegativeNeutralStrong Positive

MODERATELY BULLISH

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

No summary available yet for this article.

What did this article say?

Iridium Communications will release its second‑quarter 2026 financial results on Wednesday, July 22, 2026. The release follows the company’s definitive agreement to be acquired by Rocket Lab Corporation (RKLB). Because of the pending transaction, Iridium will not host a conference call to discuss the results. Investors should note the release date and the absence of a call when planning their analysis.

What did this article say?

Rocket Lab’s shares have risen 118 % over the past year, prompting a buy recommendation in the article. The piece highlights the stock’s strong performance but does not cite specific catalysts. Investors should consider the company’s launch cadence and earnings guidance when evaluating the recommendation. Monitoring upcoming launches and quarterly guidance will be key to assessing future upside.

What did this article say?

Rocket Lab shares rose as traders evaluated the $8B Iridium satellite connectivity deal and a $3.6B bridge loan. The deal could generate recurring revenue streams from satellite connectivity. The bridge loan provides liquidity and supports ongoing operations. The market reaction reflects optimism about the company's growth prospects. Traders should monitor the finalization of the Iridium agreement and the terms of the bridge loan.

What did this article say?

Insiders of Rocket Lab (RKLB) sold shares totaling $286,410,196, according to a recent SEC filing. The volume of shares liquidated suggests a potential shift in insider confidence. This activity may influence short‑term market sentiment and could prompt a review of the company’s strategic direction. Traders should consider how this sale aligns with RKLB’s broader financial health and upcoming disclosures.

What did this article say?

RKLB’s stock fell sharply this week after CEO Peter Beck’s trust sold $286 million of shares, signaling potential dilution and eroding investor confidence. Retail investors reacted negatively, further weighing on the stock’s price. The sell‑off raises questions about the company’s capital structure and future funding needs. Traders should assess whether the share sale reflects a strategic move or a liquidity concern. The market’s reaction underscores the importance of monitoring any forthcoming guidance or regulatory updates that could clarify the company’s outlook.

What did this article say?

Morgan Stanley lifted its target for Rocket Lab to $293, citing the Iridium acquisition as a key driver toward a vertically integrated space platform. The brokerage highlighted launch and connectivity opportunities that could mirror SpaceX’s model, reinforcing its Overweight rating. The firm also reiterated a $105 price target, implying a 26% upside from current levels. This upgrade follows a broader review of Rocket Lab’s valuation post‑SpaceX IPO and the company’s commercial progress.

What did this article say?

Morgan Stanley has set a bullish target of $293 for Rocket Lab (RKLB). The stock has fallen 17.94% over the past week and 24.23% over the past month amid a broader sell‑off in the space sector following SpaceX’s June 2026 IPO. Despite the pullback, RKLB remains up 19.57% year‑to‑date, reflecting long‑term growth expectations. The target reflects confidence in Rocket Lab’s launch cadence and future contract pipeline.

What did this article say?

Rocket Lab (RKLB) confirmed success on the U.S. Space Force’s VICTUS HAZE rapid‑response mission, showcasing its end‑to‑end launch and on‑orbit capabilities. The company has secured additional contract wins and is pursuing a planned acquisition of Iridium, which could broaden its payload offerings. Nevertheless, RKLB’s share price has slipped 24.23% over the past month, and its one‑year total shareholder return remains under pressure. The valuation debate continues as investors weigh the recent operational wins against the current market environment.

What did this article say?

Following the $8B deal, investors are reassessing Rocket Lab’s valuation. The discounted cash flow estimate remains close to the current market price, but the company’s multiples still appear elevated. The 12‑fold return over three years has already incorporated significant upside, making it unclear if further upside is justified. The acquisition of Iridium and ongoing launch commitments continue to shape the company’s growth narrative.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

No summary available yet for this article.

What did this article say?

RKLB·Rocket Lab USA Inc.

EPS

Revenue

RKLB Stock Snapshot

News Sentiment Analysis

Recent News Coverage

Discover More

News Sentiment Analysis

Recent News Coverage

Discover More